ScholarIQanswers from OpenAlex & ORCID
John D. Davis
ResearcherPublications, citations & collaboration network
John D. Davis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John D. Davis have?
ScholarIQindexed works
John D. Davis has 341 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John D. Davis have?
ScholarIQcitation count
John D. Davis has 19,161 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John D. Davis?
ScholarIQh-index
John D. Davis has an h-index of 53 in OpenAlex.
What is the i10-index of John D. Davis?
ScholarIQi10-index
John D. Davis has an i10-index of 188 in OpenAlex.
What is the ORCID of John D. Davis?
ScholarIQorcid
The ORCID for John D. Davis is on the source record.
What is the OpenAlex record for John D. Davis?
ScholarIQopenalex
The OpenAlex for John D. Davis is on the source record.
What are the most-cited papers on John D. Davis?
ScholarIQmost cited works
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Mark Boguniewicz, Lawrence Sher, Melinda Gooderham, Lisa A. Beck, Emma Guttman‐Yassky, David M. Pariser, Andrew Blauvelt, Jamie Weisman, Benjamin Lockshin, Thomas Hultsch, Qin Zhang, Mohamed Kamal, John D. Davis, Bolanle Akinlade, Heribert Staudinger, Jennifer D. Hamilton, Neil M.H. Graham, Gianluca Pirozzi, Abhijit Gadkari, Laurent Eckert, Neil Stahl, George D. Yancopoulos, Marcella Ruddy, Ashish Bansal
Conjunctivitis in dupilumab clinical trials
Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence Sher, Jamie Weisman, John T. O’Malley, Naimish Patel, Megan Hardin, Neil M.H. Graham, Marcella Ruddy, Xian Sun, John D. Davis, Mohamed Kamal, Faisal A. Khokhar, David M. Weinreich, George D. Yancopoulos, Bethany Beazley, Ashish Bansal, Brad Shumel
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Mette Deleuran, Diamant Thaçi, Lisa A. Beck, Marjolein de Bruin‐Weller, Andrew Blauvelt, Seth Forman, Robert Bissonnette, Kristian Reich, Weily Soong, Iftikhar Hussaın, Peter Foley, Michihiro Hide, Jean‐David Bouaziz, Joel M. Gelfand, Lawrence Sher, Marie L. A. Schuttelaar, Chen Wang, Zhen Chen, Bolanle Akinlade, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Heribert Staudinger, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis
Margitta Worm, Eric L. Simpson, Diamant Thaçi, Robert Bissonnette, J.‐P. Lacour, Stefan Beissert, Makoto Kawashima, Carlos Ferrándiz, Catherine Smith, Lisa A. Beck, Kuo‐Chen Chan, Zhen Chen, Bolanle Akinlade, Thomas Hultsch, Heribert Staudinger, Abhijit Gadkari, Laurent Eckert, John D. Davis, Manoj Rajadhyaksha, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu